Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 495 for cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study Of Exploring Health Communication Message Factors That Influence Cancer Research Recruitment

    Jacksonville, FL, Rochester, MN

  2. Study Of Daraxonrasib (RMC-6236) In Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. First In Human Study Of TORL-4-500 In Participants With Advanced Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study To Evaluate Safety, PK, PD And Efficacy Of AZD5492, A T Cell-engaging Antibody Targeting CD20 In Subjects With R/R B-Cell Malignancies.

    Rochester, MN

  5. Investigation Of Ubamatamab Combination Therapy In Adult Participants With Platinum-Resistant Ovarian Cancer

    Jacksonville, FL

  6. Autologous, MUC1-Activated T Cells Expanded From Peripheral Blood In Patients With Relapsed And Resistant Ovarian Cancer

    Scottsdale/Phoenix, AZ

  7. Study Of PSMA-targeted Therapy And Androgen Receptor Suppression In Low-volume Metastatic ProstatE Cancer: SPARKLE Trial

    Rochester, MN

  8. Phase II Trial Of Single Agent Belzutifan Or Pembrolizumab Versus Combination As Neoadjuvant Therapy In Clear Cell Renal Cell Carcinoma (BLAZE)

    Rochester, MN

  9. A Study Of A Selective ERBB2 Inhibitor (CGT4255), In Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Study Of KITE-363 Or KITE-753 In Participants With Relapsed And/or Refractory B-cell Lymphoma

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer